BioCryst Pharmaceuticals Announces Appointment Of Thomas Staab As Its Next Chief Financial Officer

Executive Vice President, CFO and Treasurer of Inspire Pharmaceuticals from May 2003 through its $430 million acquisition by Merck & Co., Inc. in May 2011. Prior to joining Inspire, he held senior financial positions of Acting CFO and Treasurer at...